Cargando…
A SUMO-dependent interaction between Senataxin and the exosome, disrupted in the neurodegenerative disease AOA2, targets the exosome to sites of transcription-induced DNA damage
Senataxin (SETX) is an RNA/DNA helicase implicated in transcription termination and the DNA damage response and is mutated in two distinct neurological disorders: AOA2 (ataxia oculomotor apraxia 2) and ALS4 (amyotrophic lateral sclerosis 4). Here we provide evidence that Rrp45, a subunit of the exos...
Autores principales: | Richard, Patricia, Feng, Shuang, Manley, James L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814643/ https://www.ncbi.nlm.nih.gov/pubmed/24105744 http://dx.doi.org/10.1101/gad.224923.113 |
Ejemplares similares
-
SETX sumoylation: A link between DNA damage and RNA surveillance disrupted in AOA2
por: Richard, Patricia, et al.
Publicado: (2014) -
Effects of senataxin and RNA exosome on B-cell chromosomal integrity
por: Kazadi, David, et al.
Publicado: (2020) -
Structure of an Aprataxin–DNA complex with insights into AOA1 Neurodegenerative Disease
por: Tumbale, Percy, et al.
Publicado: (2011) -
Human Senataxin Resolves RNA/DNA Hybrids Formed at Transcriptional Pause Sites to Promote Xrn2-Dependent Termination
por: Skourti-Stathaki, Konstantina, et al.
Publicado: (2011) -
Microglial Exosomes in Neurodegenerative Disease
por: Guo, Min, et al.
Publicado: (2021)